Skip to Navigation Skip to Search Skip to Content
Search All Centers

The Use of Selinexor (Xpovio) in Multiple Myeloma Treatment

Published on May 10, 2021

How is Selinexor (Xpovio) Used to Treat Multiple Myeloma?

In this segment of our Multiple Myeloma Ask the Expert series, Patient Power co-founder and patient advocate Andrew Schorr talks to Dr. Clifton Mo, MD, Medical Oncologist and Director of Autologous Stem Cell Transplantation for Multiple Myeloma at the Dana-Farber Cancer Institute, about the use of selinexor (Xpovio) in multiple myeloma treatment. This includes an explanation of the mechanism of action within the drug and how it inhibits specific proteins in the nucleus of a cancer cell.

Recommended Programs: